A stem cell transplant procedure that aims to treat severe eye injuries is being tested in the U.S, and has shown promising results in its initial phase. The treatment, which has been designed to help patients recover from "limbal stem cell deficiency," a corneal disorder that can happen after chemical burns and other eye injuries, is now being tested in a larger study.